Mumps is a highly transmissible but usually benign disease consisting of bilateral swelling of the salivary glands. In some instances, though, clinical complications can arise. Bilateral orchitis and clinical self-limited meningitis or more serious complications, such as encephalitis, deafness, male sexual sterility, and pancreatitis, may occur in rare cases (9).
Mumps is a highly transmissible but usually benign disease consisting of bilateral swelling of the salivary glands. In some instances, though, clinical complications can arise. Bilateral orchitis and clinical self-limited meningitis or more serious complications, such as encephalitis, deafness, male sexual sterility, and pancreatitis, may occur in rare cases (9) .
Mumps virus (MV), a virus belonging to the genus Rubulavirus of the subfamily Paramyxovirinae, is considered monotypic regarding its antigenicity. Thus, mumps vaccination is part of the regular immunization schedule of many countries, usually along with the measles and rubella vaccination (i.e., the MMR vaccine) in a single formulation. However, in contrast to rubella and measles, secondary vaccine failure frequently allows MV circulation within highly immunized populations (1, 5, 8, 24, 36) . The use of a poorly immunogenic genotype A strain called Rubini has been proposed as a cause of these major failures, although the occurrence of mumps in patients immunized with other vaccine strains has also been described (26) .
Genetic variation in the small hydrophobic (SH) gene has led to the characterization of 12 genotypes, which are recognized by the WHO (13, 14, 23) . Differential efficiency on cross neutralization among different genotypes has been suggested (20, 21) , as have the differential capacities of certain strains to invade the neural system (25, 32) . Finally, previous experience with the elimination programs for other preventable viral diseases, such as measles, rubella, and polio, suggest that genotyping would facilitate mumps surveillance (38) , since the pattern of viral circulation can be traced. Consequently, molecular epidemiology studies have been performed around the world (2, 7, 10, 11, 12, 15, 17, 18, 23, 31, 32, 33, 34, 35, 41) .
Mumps vaccination was introduced in the Spanish national vaccination repertoire in 1981 as part of the triple viral vaccine (the MMR vaccine). As a result, the number of mumps cases fell from 286,887 in 1984 to 1,527 in 2004. However, the general descendant trend was interrupted by some peaks: in 1989 (from 48,393 in 1987 to 83,527 in 1989), 1996 (from 7,002 in 1995 to 14,411 in 1996) , 2000 (from 2,857 in 1998 to 9,391 in 2000), and 2007 (from 1,527 in 2004 to 10,219 in 2007). Surprisingly, these peaks occurred despite a national vaccine coverage rate of over 95% of the population by 1999. As has been previously reported (29, 30) , the occurrence of vaccinated individuals with MV RNA present in their saliva and/or urine with viral IgG but not IgM in acute-phase serum was frequent, suggesting secondary vaccine failure. Although most secondary vaccine failures were associated with the use of at least one dose of the Rubini strain, cases of mumps in patients vaccinated with two doses of the Jerryl Lynn strain were also observed (29, 30) .
In this report, we describe the MV genotypes circulating in Spain over the past 8 years. This represents the first series of data obtained for the national level. Interestingly, this series comprises three different epidemic peaks with two interepidemic periods with scarce viral circulation, allowing comparison of the pattern of genotype circulation under different epidemiological conditions. Nucleic acid extraction. Total nucleic acids were extracted from 100 l of the original specimen with a Magna Pure LC total nucleic acid isolation kit in a Magna Pure LC automatic extractor (Roche Diagnostics, Mannheim, Germany). Nucleic acids were resuspended in a final elution volume of 50 l. Ten thousand molecules of synthetic RNA were included in the lysis solution as an internal control (6) .
MATERIALS AND METHODS

Samples
Amplification and sequencing methods. Initial screening of sets 1 and 2 was performed by a previously described RT-PCR method, but we used a slight modification (22) . The modification consisted of performance of the reverse transcription and the first amplification in a single step by means of the Access RT-PCR system kit (Promega Co., Madison, WI). Genotyping of the MVpositive samples was done by partial sequencing of the SH gene (23) . Set 3 was studied directly by the genotyping RT-PCR described previously (23) .
Sequence analysis. Sequences were assigned to a given genotype by comparison with the sequences of reference strains (13) . Subgrouping within genotypes H, G, and D was performed as described by Palacios et al. (23) . The sequences were aligned by the use of Clustal X software and were analyzed by the MEGA (version 2.1) program. Phylogenetic trees were obtained by using the neighborjoining and the Kimura two-parameter model of substitution with 1,000 bootstrap replications. Additional analysis by Bayesian inference with MrBayes (version 3.1) software improved the strength of the genotype assignation, when necessary (see below). When discrepancies with published data arose, the whole SH gene was sequenced to apply the reference criteria for genotype definition on the basis of simple homology (13) .
Nucleotide sequence accession numbers. The GenBank accession numbers of the nucleotide sequences obtained in this study are found in Table 1 .
RESULTS
Genotype assignation of sequences obtained from samples.
Six different MV genotypes (A, C, D, G, H, and J) were identified to have been circulating in Spain. Assignment to genotypes C, G, and H was based on low significant bootstrap values in the initial neighbor-joining phylogenetic analysis. Subsequent analysis by Bayesian inference clustered every sequence to a known genotype with significant bootstrapping values (Fig. 2) .
Of the 237 sequences obtained, 134 were identical sequences obtained from specimens collected between 2005 and 2007 (and represented in the tree as strain 804O05) and were classified as genotype G. These sequences were also identical to sequences obtained from mumps outbreaks in the United States and Canada in 2006 (37) and to the previously published sequence Ast/SP07. While the North American sequences had been characterized as genotype G, the sample collected in Asturias, Spain, in 2007 was proposed to be part of a new genotype whose reference strain would be strain UNK02-19 (4). To resolve this discrepancy, the entire SH gene (GenBank accession no. AM766002) was sequenced. Strain 804O05 was greater than 97.5% homologous with both genotype G reference strains but less than 92.7% homologous with the reference strains of the other genotypes as well as 92.4% homologous with strain UNK02-19. According to these data and following the criterion of the need for 95% homology in the 2485NE  FJ919343  1  Pontevedra  2005  G1  1501O  FJ919344  2  Almería  2005  G1  2006O  FJ919345  2  Logroño  2006  G1  804O  FJ919346  134  Almería  2005  G1  1028O  FJ919347  2  Almería  2005  G1  772O  FJ919348  1  Cáceres  2007  G1  2393O  FJ919349  1  Segovia  2007  G1  3736O  FJ919350  2  Logroño  2006  G1  1459O  FJ919351  2  Madrid  2005  G1  2384O  FJ919352  1  Madrid  2007  G2  591O  FJ919353  13  Madrid  2005  H2  1337O  FJ919354  1  Madrid  2005  H2  2104O  FJ919355  31  Madrid  2000  H1  8Canarias  FJ919356  1  Las Palmas de  Gran Canaria   2000  H1   1295O  FJ919357  1  Palencia  2002  H1  10Canarias FJ919358  1  Las Palmas de  Gran Canaria   2000  H1   556O  FJ919359  4  Madrid  2001  H1  646O  FJ919360  1  Madrid  2001  H1  1269O  FJ919361  10  Madrid  2000  H1  857NE  FJ919362  2  Ferrol  1996  H1  1290O  FJ919363  1  Madrid  2005  H1  985O  FJ919364  8  Almería  2000  D1  9820  FJ919365  1  Madrid  2001  D1  1818O  FJ919366  2  Ceuta  2007  D1  1913O  FJ919367  2  Ceuta  2007  D1  878O  FJ919368  3  Murcia  2006  C  1610NE  FJ919369  1  Alicante  1999  C  2780O  FJ919370  3  Madrid  2003  J  167O  FJ919371  2 whole SH gene (13, 38) to be able to assign a sequence to a preexisting genotype, both Ast/SP07 and our sequences of the same cluster belonged to genotype G. Genotype circulation. The different MV genotypes identified in this study are listed in Fig. 1 (Fig. 1) . Spanish strains clustered within the genotype H1 branch (Fig. 3 ) with other strains from Switzerland, the United Kingdom, and Argentina recovered in the same years, as well as with a group of sequences from Belarus (3). Genotype D1 strains were the most similar to those from an outbreak in Portugal in 1996 within a bigger genotype D1 group containing contemporary strains from other countries in Europe (Fig. 4) . A single sequence of genotype C detected in 1999 was similar to the sequences of a group of strains circulating in Switzerland at that time (Fig. 5 ). Two cases with the same genotype A sequence were also detected in Madrid in January and February of 2001, together with genotypes H1 and D1. The comparison of this sequence with other genotype A sequences showed striking differences from the sequences of both vaccine and wild-type strains ( Table 2 ). The positive controls used in the laboratory were also included to rule out laboratory contamination. According to these data, these two sequences seem to be those of new wild-type strains of genotype A. Both patients had received a single dose of vaccine 5 and 8 years before the mumps episode, respectively, and their vaccination records did not show that they had received further vaccinations. Further investigation is needed for the definitive classification of this strain, since the circulation of wild-type strains of genotype A has not been reported in recent years.
The number of notifications started to increase again in 2005 due to simultaneous outbreaks caused by genotype H2 strains in Segovia (Castilla-León, central Spain) and genotype G1 strains in Almería (Andalusia, southern Spain) from May to July, causing concomitant individual cases in Madrid together with others caused by genotype J (Fig. 1) . These genotype H2 strains clustered with a group of sequences from Israel and Palestine collected in 2004 (Fig. 3) (28, 37) (Fig. 6) .
DISCUSSION
Genotyping is a basic tool used for epidemiological surveillance of vaccine-preventable viral diseases. In order to provide these surveillance programs with universal tools enabling worldwide surveillance, the WHO has established standard genotype nomenclature, reference strains, and target genomic sequences for the viruses included in the triple viral MMR vaccine: measles virus (39), mumps virus (13, 38) , and rubella virus (40) . Data from as many countries as possible are required to understand the epidemiological significance of genotyping data. However, in the case of the mumps virus, the amount of available data is far from optimal. In this work, we contribute the first series of data covering a period of 10 years on the MV genotypes in general circulation in Spain.
Previous available data on local outbreaks in San Sebastian (18), Valencia (27) , and Asturias (4) concur with our data. The dominance of a single genotype at the national level was associated with periods of reporting of high rates of mumps to the national surveillance system.
In this series, three epidemic waves of mumps cases were observed. Interestingly, dominant genotype replacement occurred after mumps reporting decreased to minimum levels. Genotype H1 was dominant between 1999 and 2003 but was successfully replaced by G1 after a "silent" period of 2 years with scarce mumps circulation. On the other hand, although data from 1996 to 1998 are limited, the genotype H1 strain was also detected during that period, suggesting that the end of an epidemic wave was not always followed by a genotype replacement. Although a temporal shift in MV genotype circulation was described previously (10, 11, 12, 16, 26, 33) , we believe that this is the first report establishing a link between cyclic variations, genotype, and mumps prevalence.
The pattern observed during the epidemic waves (the circulation of a dominant genotype) seems to reflect continuous viral circulation, in accordance with the clinical data. Even though the rates of vaccine coverage were identically high for measles and mumps viruses, the measles virus showed a different pattern (e.g., a variety of genotypes associated with unrelated local outbreaks) (19) . The latter pattern correlates with the interruption of measles virus circulation at the national level, as reflected by case reports (19) . These results highlight the relatively low efficiency of the mumps vaccine in comparison with that of the measles vaccine. The use of the Rubini strain in Spain between 1993 and 1999 for mumps vaccination could be an important factor to explain this low efficiency. Interestingly, genotype H2 strains were not able to establish circulation at the national level, even though they caused a local outbreak in Segovia that radiated cases to Madrid. However, genotype G1 succeeded in spreading shortly after that. The same G1 strain was also reported from many other parts of the world (28, 37) , suggesting an enhanced ability to spread within vaccinated populations. Similarly, another genotype, genotype D1, was able to establish circulation concomitantly with the dominant genotype, genotype H1, during 2000 and 2001, as reported in Switzerland (35) . The selective forces that led to the extinction of circulating genotypes and caused the further onset of particular strains are unknown. The differential ability of vaccine-induced antibodies to neutralize different MV genotypes suggested by some authors (21) might account for part of the explanation for these positive selection events; we believe that our data support this theory and that they thus warrant additional investigation. The different histories of genotype importation, the variations in vaccine coverage rates, and the use of different vaccine strains in each country draw a complex global picture that could be the cause of the different geographical patterns of mumps virus genotype circulation observed in the United Kingdom (12), Japan (31) , and Switzerland (35) .
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